Each company’s analysis provides:U.S. and international sales and operating profit estimates by division, geographic region, therapeutic category, and individual drug.Five-year sales and operating profit performance.The companies analyzed in the report: - AstraZeneca - Bristol-Myers Squibb - GlaxoSmithKline - Johnson & Johnson - Merck - Novartis - Pfizer - Roche - Sanofi-Aventis - WyethContains 130 pages and 92 tables